logo BDSP

Base documentaire

  1. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

    Article - En anglais

    Cost-benefit analyses can be integral to the evaluation of interventions in developing countries.

    The authors compare the potential benefits to the Chilean Ministry of Health, in terms of treatment costs averted, by prevention of Haemophilus influenzae type b (HIB) invasive disease, with the costs of adding HIB conjugate vaccine to the diphtheria-tetanus-pertussis (DTP) immunization routinely administered to infants.

    In their base-case model, over a 10-year period (1991-2000), vaccination against HIB will prevent 1,229 cases of HIB invasive disease, including 713 cases of meningitis, 107 of whom would suffer severe, long-term sequelae, and between 29 and 116 deaths.

    Mots-clés Pascal : Méningite, Prévention, Economie santé, Haemophilus influenzae, Pasteurellaceae, Bactérie, Vaccination, Système nerveux pathologie, Vaccin associé, Analyse avantage coût, Homme, Pays en développement, Système nerveux central pathologie, Chili, Amérique du Sud, Amérique, Modèle

    Mots-clés Pascal anglais : Meningitis, Prevention, Health economy, Haemophilus influenzae, Pasteurellaceae, Bacteria, Vaccination, Nervous system diseases, Mixed vaccine, Cost benefit analysis, Human, Developing countries, Chile, South America, America, Models

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 93-0549337

    Code Inist : 002B05C02A. Création : 199406.